Loading…
Reported covered position: President
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
OCULAR THERAPEUTIX, INC. via SONORAN POLICY GROUP, LLC D/B/A STRYK GLOBAL DIPLOMACY, FORMERLY KNOWN AS SONORA
2026 · third_quarter · RR
Pharmaceutical manufacturing issues
COLLEGIUM PHARMACEUTICAL, INC. via SONORAN POLICY GROUP, LLC D/B/A STRYK GLOBAL DIPLOMACY, FORMERLY KNOWN AS SONORA
2026 · first_quarter · RR
Source: Senate LDA
U.S. Executive Branch engagement
District of Columbia interactions with U.S. Congress.
District of Columbia interactions with U.S. Congress.